title: Predictors for Tolvaptan Treatment and Future Perspectives.
authors.affiliation: Department of Cardiovascular Medicine, Graduate School of Medicine, The University of Tokyo.
authors.forename: Daisuke
authors.initials: D
authors.lastname: Nitta
mesh_terms: D000450:Aldosterone / Q000097:blood; D065092:Antidiuretic Hormone Receptor Antagonists / Q000627:therapeutic use*; D001120:Arginine / Q000097:blood / Q000187:drug effects; D001552:Benzazepines / Q000627:therapeutic use*; D015415:Biomarkers / Q000097:blood; D004231:Diuresis / Q000187:drug effects; D004305:Dose-Response Relationship, Drug; D019317:Evidence-Based Medicine; D006333:Heart Failure / Q000175:diagnosis / Q000188:drug therapy* / Q000378:metabolism / Q000503:physiopathology; D006801:Humans; D011237:Predictive Value of Tests; D011379:Prognosis; D012084:Renin-Angiotensin System / Q000187:drug effects; D012680:Sensitivity and Specificity; D012720:Severity of Illness Index; D000077602:Tolvaptan; D016896:Treatment Outcome; D014667:Vasopressins / Q000097:blood / Q000187:drug effects
chemical_list: D065092:Antidiuretic Hormone Receptor Antagonists; D001552:Benzazepines; D015415:Biomarkers; D014667:Vasopressins; D000077602:Tolvaptan; D000450:Aldosterone; D001120:Arginine